CN111700997A

CN111700997A - Medicine for treating spinal diseases and auxiliary treatment device

Info

Publication number: CN111700997A
Application number: CN202010623108.1A
Authority: CN
Inventors: 瞿兴平
Original assignee: Individual
Current assignee: Individual
Priority date: 2020-06-30
Filing date: 2020-06-30
Publication date: 2020-09-25
Anticipated expiration: 2040-06-30
Also published as: CN111700997B

Abstract

The application relates to the field of traditional Chinese medicines and discloses a medicine for treating spinal diseases and an auxiliary treatment device, wherein the medicine comprises the following components: rhizoma Polygoni Cuspidati, Notopterygii rhizoma, radix Angelicae Pubescentis, radix Clematidis, radix Aconiti Kusnezoffii, rhizoma arisaematis preparata, Curcuma rhizome, lignum sappan, caulis Spatholobi, cortex Erythrinae, herba Speranskiae Tuberculatae, rhizoma homalomenae, cortex Schizophragmatis Integrifolii Radicis, radix Gentianae Marcrophyllae, radix Cynanchi Paniculati, radix Angelicae sinensis, Carthami flos, rhizoma Ligustici Chuanxiong, and ramulus Cinnamomi. The medicament is mainly used for treating qi stagnation and blood stasis, cold dampness and rheumatism obstruction type lumbar disc herniation and spinal pain, and meanwhile, the auxiliary treatment device is used for vertically drawing the spinal part, so that the spinal is physically drawn under the action of drawing force and the gravity of a human body, gaps among the spinal vertebrae of the spinal are properly enlarged, the original dislocated spinal vertebrae are slightly restored, and the medicament is matched with the medicament for treatment to directly reach focuses, so that the effects of treating early spinal diseases and relieving the pain of patients are achieved.

Description

Medicine for treating spinal diseases and auxiliary treatment device

Technical Field

The invention relates to the field of traditional Chinese medicines, in particular to a medicine for treating spinal diseases and an auxiliary treatment device.

Background

The spine has functions of supporting the trunk, protecting the internal organs, protecting the spinal cord, and performing exercise. "spinal dislocation" refers to a subtle change in the relationship between bones, but due to the complexity of the spinal structure, minimal dislocation can cause long-term severe pain and has a great impact on daily life.

At present, non-operative comprehensive treatment is mainly used in treatment, and traditional Chinese medicine treatment is an important means of non-operative treatment, and generally comprises means of oral medicine, external plaster, massage and the like. However, oral administration generally adopts a treatment method of tonifying kidney and strengthening tendons, nourishing blood and promoting blood circulation, and dredging collaterals and relieving pain, and the pain relieving effect is good, but the disease condition is easy to repeat because dislocated bones are not recovered. External plasters also have the action of relieving pain, while tuina relies on long-term treatment to prevent repeated disease states.

Disclosure of Invention

In order to solve the problems of low cure rate and easy relapse of the state of an illness existing in the prior art, the application provides a medicament for treating the spinal diseases and an auxiliary treatment device.

In order to achieve the purpose, the technical scheme adopted by the application is as follows:

an external medicine for treating spinal diseases comprises the following raw materials: 10-15g of garden balsam stem, 5-10g of obscured homalomena rhizome, 9-12g of schizophragma integrifolium, 5-10g of large-leaved gentian, 5-10g of paniculate swallowwort root, 8-12g of Chinese angelica, 6-12g of safflower, 5-10g of szechuan lovage rhizome, 5-10g of sappan wood, 8-12g of turmeric and 4-6g of white mustard seed.

The medicinal mechanism of the raw materials in the scheme is as follows:

rhizoma Polygoni Cuspidati is rhizome and root of Polygonum cuspidatum cuspidoum Sieb. et Zucc. of Polygonaceae, has slightly cold nature, and enters liver channel, gallbladder channel and lung channel, and has effects of dispelling pathogenic wind, promoting diuresis, removing blood stasis, relieving pain, relieving cough and eliminating phlegm;

notopterygium root, which is dried rhizome and root of Notopterygium incisum Ting ex H.T. Chang or Notopterygium forbesii H.de Boiss, Franchetii H.de Boiss, belonging to Umbelliferae, with warm nature, entering bladder channel and kidney channel, relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, removing dampness, and relieving pain;

radix Angelicae Pubescentis, which is root of Angelica gigas Maxim.f. biserrata Shannet Yuan of Umbelliferae, has mild sexual potency, enters kidney meridian and bladder meridian, and has effects of dispelling pathogenic wind, removing dampness, relieving arthralgia, and relieving pain;

clematis chinensis Osbeck, Clematis chinensis, Clematishaxacetala pall or Clematishakuri manshurica Rupr, which belongs to Ranunculaceae, has warm nature, enters bladder channel, dispels wind and dampness, and unblocks collaterals to relieve pain;

radix Aconiti is dried mother root of Aconitum carmichaeli Debx. of Ranunculaceae, and is effective in warming heart channel, liver channel, kidney channel, and spleen channel, dispelling pathogenic wind, removing dampness, warming channels, and relieving pain;

radix Aconiti Kusnezoffii, root tuber of Aconitum kusnezoffii Reichb of Ranunculaceae, with heat, heart channel, liver channel, kidney channel, and spleen channel, and has effects of dispelling pathogenic wind, removing dampness, dispelling cold, and relieving pain;

soaking clean rhizoma arisaematis in water according to size, respectively, changing water for 2-3 times every day, adding Alumen (2 kg for every 100kg rhizoma arisaematis) when foaming, changing water for one day, taking out rhizoma arisaematis when the cut opening tastes light tongue and tongue, and adding rhizoma Zingiberis recens and Alumen 12.5kg respectively. The processed rhizoma arisaematis has the effects of dispelling pathogenic wind, relieving spasm, resolving hard mass and eliminating swelling;

turmeric, Curcuma Longae Rhizoma, rhizome of Curcuma longa L. of Zingiberaceae, with warm nature, enters spleen channel and liver channel, breaks blood, promotes qi circulation, and relieves pain;

dried heartwood of Sappan wood, Sappan Lignum, Sappan wood, Caesalpinia Sappan l. of leguminosae, with mild nature, entering heart, liver and spleen meridians, promoting blood circulation, removing blood stasis and relieving pain;

caulis Spatholobi, rattan of Spatholobus suberectus Dunn of Leguminosae, is warm in nature, enters liver channel and kidney channel, and is effective in replenishing blood, promoting blood circulation, and dredging collaterals;

erythrina bark, bark of Erythrina variegata l.var.orientalis (L.) merr.of leguminous plant, neutral in nature, entering liver and spleen meridians, expelling wind-damp, dredging meridians and relieving pain;

herba speranskiae tuberculatae, a dry aerial part of the leaf of Speranskia Tuberculata (Bunge) Baillon of Euphorbiaceae, warm in nature, entering kidney and liver meridians, expelling wind and removing dampness, relaxing muscles and tendons, promoting blood circulation, removing blood stasis, relieving swelling, removing toxic substance, and relieving pain;

homalomena occulta (rhizome of Homalomena occulta (Lour.) Schott. of Araceae), with warm nature, and effects in invigorating kidney and liver meridians, dispelling pathogenic wind, removing dampness, and strengthening tendons and bones;

cortex Schizophragmatis Integrifolii Radicis (Franch.) of Saxifragaceae, with cold nature, spleen meridian tropism, muscles and tendons relaxing, collateral flow activating, pathogenic wind dispelling, and blood circulation promoting effects;

radix Gentianae Macrophyllae, root of Gentiana macrophylla pall. of Gentianaceae, neutral in nature, entering stomach meridian, liver meridian, and gallbladder meridian, relaxing muscles and tendons, and relieving pain;

the root and rhizome of paniculate swallowwort root and rhizome of Cynanchum paniculatum (Bge.) of the family of stemonaceae, warm in nature, enter liver and stomach meridians, expel wind and remove dampness, and promote qi circulation to remove meridian obstruction; in this protocol, the effects of analgesia and inhibition of platelet aggregation are used primarily.

Angelica sinensis, root of Angelica sinensis (Oliv.) Diels, Umbelliferae, with warm nature, enters liver, heart and spleen meridians, and has effects of replenishing blood, promoting blood circulation and relieving pain;

carthami flos, flower of Carthamus tinctorius L. of Compositae, with warm nature, heart meridian and liver meridian entered, and effects of promoting blood circulation, dredging channels, removing blood stasis and relieving pain;

rhizoma Ligustici Chuanxiong, rhizome of Ligusticum chuaxiong Hort of Umbelliferae, is warm in nature, and enters liver meridian, gallbladder meridian and pericardium meridian, and has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind, relieving pain, and relieving spasm;

ramulus Cinnamomi is dry twig of Cinnamomum Cassia Presl of Lauraceae, and has warm nature, and is effective in regulating meridians, lung and bladder, inducing sweat, expelling pathogenic factors from muscles, warming and dredging channels, supporting yang, regulating qi, and calming the adverse-rising energy.

Further, the method comprises the following raw materials:

each part of the traditional Chinese medicine composition comprises 30g of giant knotweed rhizome, 12g of notopterygium root, 12g of pubescent angelica root, 12g of clematis root, 12g of common monkshood mother root, 12g of kusnezoff monkshood root, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 12g of suberect spatholobus stem, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of paniculate swallowwort root.

In the invention, the giant knotweed rhizome is used as a monarch drug to dispel wind and remove dampness; notopterygium root, radix angelicae pubescentis, radix clematidis, radix aconiti agrestis and processed rhizoma arisaematis are used as ministerial drugs for dispelling cold and relieving pain; turmeric, sappan wood, suberect spatholobus stem, erythrina bark, garden balsam stem, obscured homalomena rhizome, schizophragma integrifolium, large-leaved gentian, paniculate swallowwort root, Chinese angelica, safflower and szechuan lovage rhizome are used as adjuvant drugs, blood enriching and activating, tendon relaxing and collateral dredging are realized, and cassia twig is used as a messenger drug, is used for warming and activating channels and collaterals and supporting yang and regulating qi. The whole formula has the effects of dispelling wind and eliminating dampness, promoting blood circulation and relieving pain, relaxing muscles and tendons and strengthening the spine, and is mainly used for treating spine diseases caused by qi stagnation and blood stasis, cold dampness and rheumatism obstruction.

Further, the preparation method comprises the following steps:

s1, grinding the raw materials into fine powder of 100 meshes;

s2, steaming the medicinal powder over water for 25-35 minutes;

s3, adding the medicinal powder obtained in the step S2 into 500ml of solvent;

and S4, placing the cold plate for at least 24 hours.

Further, the solvent is white spirit or old wine with the alcohol content of more than 50 degrees. The alcohol is used as an organic solvent, can dissolve most of effective components in the medicine in the alcohol, and is harmless to human body. In addition, old wine is pungent and warm, warms blood and vessels, guides medicine to reach disease sites, and further enhances the curative effect of the medicine.

The spinal column auxiliary treatment device comprises a traction device and a dressing containing the external medicine for treating the spinal column diseases, wherein the traction device is composed of a bearing part, a traction part and a stretching part, the bearing part is fixedly arranged at a position higher than a human body, the traction part is connected with the stretching part and the bearing part, the stretching part enables the traction force of the traction part to act on the human body to pull the spinal column along the length direction of the spinal column, and the dressing is in contact with the skin around the spinal column and is detachably connected with the traction device.

The traction device is utilized to pull the spine part, and a user adopts a sitting posture or a standing posture to physically pull the spine under the action of traction force and the self gravity of the human body, so that the pressure of the intervertebral disc is relieved, the intervertebral space is increased, the negative pressure suction force in the nucleus pulposus and the back pressure effect of the posterior longitudinal ligament on the protruded nucleus pulposus are increased, and meanwhile, the shank of inflammation is promoted, the muscle spasm is relieved, and the like. And the pain of the patient is further treated and relieved by matching with external medicine treatment in the dressing. In addition, because the dressing is disposable, the dressing and the traction device are detachably connected and are convenient to replace.

Further, tensile portion is including tying up the first bandage on the people's health, first bandage is connected with traction portion, be equipped with the connecting band on the first bandage, the other end of connecting band is connected with the second bandage. The dressing comprises a medicine bag and a fixing part, wherein a first connecting piece and a second connecting piece which are matched with each other are respectively arranged on the connecting belt and the fixing part, so that the connecting belt and the fixing part can be detachably and fixedly connected, and the medicine bag can be detachably fixed between the connecting belt and the fixing belt.

The first binding band is bound on the upper part of human body, such as armpit or chest, and is connected with the traction part, and the human body is applied with upward pulling force and acts on the spine by applying pulling force on the traction part, wherein the pulling force is less than or equal to the gravity of the human body. The second bandage can be known to play a role in stretching the medicine package, so that the medicine package can be uniformly extended along the spine of the human body, and the medicine can be uniformly applied along the spine.

It is worth mentioning that the first connecting member and the second connecting member are two parts which are mutually matched. The connecting band and the fixing part are detachably and fixedly connected, the medicine bag is not connected with any medicine bag, and the medicine bag is detachably fixed in the connecting band and the fixing part only through the connection of the connecting band and the fixing part. This arrangement facilitates replacement of the pack and also allows replacement of the dirty securing portion after a long period of use.

Further, the traction part comprises a traction rope connected with the first binding belt and a rope binder for binding the traction rope into a bundle above the first binding belt. The bearing part comprises a wheel disc, and the traction rope bypasses the wheel disc after passing through the rope bundling device. The bearing part is fixedly arranged above a human body, for example, the bearing part is fixed on a ceiling, the traction rope passes through the rope binding device and then passes through the wheel disc, and the part of the traction rope contacting with the wheel disc does not exceed the perimeter of the wheel disc. Wherein, the rim plate both plays the effect of bearing, can change the pulling force of exerting on the pulling rope into the pulling force of vertical upwards acting on first bandage again.

Further, the first binding belt comprises a structural ring bearing pulling force and a coating layer sleeved outside the structural ring, and the coating layer extends outwards on one side far away from the bearing part to form an annular secondary belt; the first binding belt is provided with a plurality of through holes at the position close to the structural ring, and the first binding belt is provided with a hanging foot structure for winding the structural ring; the lifting foot is characterized in that a single binding band material penetrates through the through hole, the first binding band is externally attached end to form an annular structure, a fixing end portion is arranged at the position of the end to end attachment, and a pressing ring convenient for pulling the end portion of the rope to exert force is arranged at the fixing end portion.

Further, be equipped with the dressing on the connecting band, the dressing includes cartridge bag and fixed part, the fixed part is network structure to all be equipped with the ligature area at last lower tip, through passing the connecting band with the ligature area and tie up behind one's back and form the fixed power to the cartridge bag.

The invention utilizes the traction device to carry out vertical traction on the spine part, so that the spine is physically pulled under the action of traction force and the self gravity of a human body, the gap between the vertebrae of the spine is properly increased, the originally dislocated vertebrae can be slightly restored, and the effects of treating early spinal curvature and relieving the pain of a patient are achieved by matching with the drug treatment in the dressing. Simultaneously, under the cooperation of tractive device, the medicine also can more with human body laminating, the backbone also absorbs the medicine with better gesture, medicine component and tractive device both bring out the best in each other.

Drawings

In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings needed to be used in the description of the embodiments or the prior art will be briefly introduced below, it is obvious that the drawings in the following description are only some embodiments of the present application, and for those skilled in the art, other drawings can be obtained according to the drawings without inventive exercise.

FIG. 1 is a line graph of data obtained from the VAS pain scores of the experimental and control groups of the present application;

FIG. 2 is a schematic view of the structure of the spinal auxiliary treatment device of the present application;

FIG. 3 is a schematic view of another angle of the spinal auxiliary treatment device of the present application;

FIG. 4 is a schematic view of the engagement of the dressing and the attachment strip in the present application;

FIG. 5 is a schematic structural diagram of example 6 of the present application;

FIG. 6 is a schematic structural diagram of another perspective of the embodiment 6 in the present application;

FIG. 7 is an enlarged view of a portion of FIG. 6 at A;

in the figure: 1-pulling rope; 2-a first strap; 201-structural ring; 202-subband; 3-dressing; 301-pack of medicine; 302-positioning holes; 303-a fixed part; 4-connecting the belt; 401 — a first connector; 5-a second strap; 6-a load bearing part; 7-hanging feet; 701-pressure ring.

Detailed Description

In order to make the objects, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the drawings in the embodiments of the present application, and it is obvious that the described embodiments are some embodiments of the present application, but not all embodiments. The components of the embodiments of the present application, generally described and illustrated in the figures herein, can be arranged and designed in a wide variety of different configurations.

Thus, the following detailed description of the embodiments of the present application, presented in the accompanying drawings, is not intended to limit the scope of the claimed application, but is merely representative of selected embodiments of the application. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.

It should be noted that: like reference numbers and letters refer to like items in the following figures, and thus, once an item is defined in one figure, it need not be further defined and explained in subsequent figures.

In the description of the present application, it should be noted that if the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc. are used for indicating the orientation or positional relationship based on the orientation or positional relationship shown in the drawings or the orientation or positional relationship which is usually placed when the product of the application is used, the description is only for convenience and simplicity, and the indication or suggestion that the referred device or element must have a specific orientation, be constructed in a specific orientation and be operated, and thus, should not be construed as limiting the present application. Furthermore, the appearances of the terms "first," "second," and the like in the description herein are only used for distinguishing between similar elements and are not intended to be construed as indicating or implying relative importance.

Furthermore, the terms "horizontal", "vertical" and the like when used in the description of the present application do not require that the components be absolutely horizontal or overhanging, but may be slightly inclined. For example, "horizontal" merely means that the direction is more horizontal than "vertical" and does not mean that the structure must be perfectly horizontal, but may be slightly inclined.

In the description of the present application, it should also be noted that, unless otherwise explicitly stated or limited, the terms "disposed," "mounted," "connected," and "connected" should be interpreted broadly, e.g., as being fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present application can be understood in a specific case by those of ordinary skill in the art.

Example 1:

an external medicine for treating spinal diseases comprises the following raw materials: 25-40g of giant knotweed rhizome, 10-15g of notopterygium root, 10-15g of radix angelicae pubescentis, 10-15g of radix clematidis, 8-12g of radix aconiti agrestis, 10-15g of prepared arisaema tuber, 8-12g of turmeric, 10-15g of sappan wood, 10-15g of suberect spatholobus stem, 10-15g of erythrina bark, 10-15g of garden balsam stem, 5-10g of obscured homalomena rhizome, 9-12g of schizophragma integrifolium, 5-10g of large-leaved gentian, 5-10g of paniculate swallowwort root, 8-12g of Chinese angelica, 6-12g of safflower, 5-10g of.

Example 2:

an external medicine for treating spinal diseases comprises the following raw materials: each part of the traditional Chinese medicine composition comprises 30g of giant knotweed rhizome, 12g of notopterygium root, 12g of pubescent angelica root, 12g of clematis root, 12g of common monkshood mother root, 12g of kusnezoff monkshood root, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 12g of suberect spatholobus stem, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of paniculate swallowwort root.

The lumbar intervertebral disc protrusion belongs to the category of pain in waist and legs (feet) and paralysis deviation in the traditional Chinese medicine. Although doctors in various generations have different types of the prolapse of lumbar intervertebral disc according to their own clinical experiences, the types of the prolapse of lumbar intervertebral disc are standardized and agreed to be the following four types in the third edition of "standard for curative effect of diagnosis of disease and syndrome of traditional Chinese medicine" and "guiding principle of clinical research of new drug of traditional Chinese medicine": blood stasis type (syndrome), cold-dampness type (syndrome), damp-heat type (syndrome), and liver and kidney deficiency type (kidney deficiency syndrome).

Blood stasis type:

the reason is as follows: it is mostly caused by lumbar sprain.

Symptoms are: the lumbago is obvious, the spinal column is bent laterally, obvious pressure pain points exist between 4 and 5 waists, the symptoms of the patient are aggravated when the patient is in cough and laughing due to radiation to the lower limbs, the muscle atrophy of the patient can be seen in the late stage of the disease, the straight leg elevation test is positive, the body position is forced, and the pulse is wiry, rapid or thready and unsmooth. The tongue is dark purple.

Cold-dampness pattern:

the reason is as follows: there is no obvious history of trauma and the condition is aggravated by dampness.

Symptoms are: pain in the waist and legs of a patient is heavy and heavy, the limbs feel wet and cold, the symptoms change with weather, lateral bending of the spine, pressure pain beside the spine or radiating pain, the patient likes warm and aversion to cold, the pulse is deep and slow, and the tongue coating is white and greasy.

Damp-heat type:

the reason is as follows: has no obvious inducement and aggravates symptoms when being heated.

Symptoms are: pain in the waist and legs, weakness of limbs, heat sensation in the pain area, aggravation of pain in hot or rainy days, aversion to heat, thirst, scanty and dark urine, wiry and rapid or soft-superficial and rapid pulse, yellow and greasy tongue coating.

Liver and kidney deficiency type:

the reason is as follows: the disease is long and not cured.

Symptoms are: the pain in the waist and legs can not be cured for a long time, the symptoms are recurrent, the muscles and bones of the patient are weak, the symptoms at the pain position are relieved, the symptoms are obviously aggravated after fatigue, the symptoms are relieved when the patient lies on the side, and sometimes, the leg is numb, the tinnitus and the deafness are accompanied, the pulse is wiry, thin and weak, and the tongue is pale and white.

The components of the invention can be matched to expel wind and remove dampness, promote qi and blood circulation, and dredge collaterals and relieve pain, and is suitable for symptoms of qi stagnation and blood stasis, cold dampness and rheumatism obstruction.

Example 3:

the preparation method comprises the following steps: s1, grinding the raw materials into fine powder of 100 meshes; s2, steaming the medicinal powder over water for 25-35 minutes; s3, adding the medicinal powder obtained in the step S2 into 500ml of solvent; s4, placing the mixture on a cold plate for 24 hours. Preferably, the solvent is selected from Chinese liquor or aged wine with alcohol degree of more than 50.

Effect verification:

1. case selection criteria

Inclusion criteria were: the western medicine can be used for conservative treatment of the lumbar intervertebral disc protrusion, and the traditional Chinese medicine can be used for diagnosing patients with lumbocrural pain or arthralgia and patients with qi stagnation, blood stasis or rheumatism obstruction, and the age is 25-55 years old.

Exclusion criteria: under 25 years of age or over 55 years of age; women with difficulty in moving during menstrual period, gestation period and lactation period; patients with allergic constitution or allergy to the drugs include patients with serious diseases such as cardiovascular and cerebrovascular diseases, liver diseases, kidney diseases, and hematopoietic system diseases.

2. Experimental group and control group settings

One experimental group and four control groups were set, with 10 cases each.

Experimental groups: 30g of giant knotweed rhizome, 12g of notopterygium root, 12g of pubescent angelica root, 12g of clematis root, 12g of common monkshood mother root, 12g of kusnezoff monkshood root, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 12g of suberect spatholobus stem, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of paniculate swallowwort root, 10g of Chinese angelica, 10g of safflower, 10g of szechuan lovage rhizome and 6g of cassia twig are prepared.

Control group 1: 12g of notopterygium root, 12g of radix angelicae pubescentis, 12g of radix clematidis, 12g of radix aconiti agrestis, 12g of rhizoma arisaematis preparata, 12g of turmeric, 12g of sappan wood, 12g of caulis spatholobi, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of gentiana macrophylla, 10g of cynanchum paniculatum, 10g of angelica, 10g of safflower, 10g of ligusticum wallichii and 6g of cassia twig are prepared into the.

Control group 2: 30g of giant knotweed rhizome, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 12g of suberect spatholobus stem, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of paniculate swallowwort root, 10g of Chinese angelica, 10g of safflower, 10g of szechuan lovage rhizome and 6g of cassia twig are prepared into the external medicine according to the preparation method of an experimental group.

Control group 3: 30g of giant knotweed rhizome, 12g of notopterygium root, 12g of pubescent angelica root, 12g of clematis root, 12g of common monkshood mother root, 12g of kusnezoff monkshood root, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of paniculate swallowwort root and 6g of cassia twig are prepared into the external medicine according.

Control group 4: 30g of giant knotweed rhizome, 12g of notopterygium root, 12g of pubescent angelica root, 12g of clematis root, 12g of common monkshood mother root, 12g of kusnezoff monkshood root, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 12g of suberect spatholobus stem, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of Chinese angelica, 10g of safflower and 10g of Sze.

It is worth explaining that the experimental group uses the medicine components in the example 2, compared with the medicine components of the experimental group, the comparison group 1 excludes the monarch drug giant knotweed rhizome, the comparison group 2 excludes the notopterygium root, the radix angelicae pubescentis, the clematis root, the monkshood and the radix aconiti agrestis which have the functions of dispelling wind and eliminating dampness and are also the main part of the ministerial drugs, the comparison group 3 excludes the spatholobus stem, the angelica, the safflower and the ligusticum wallichii which have the functions of enriching the blood and activating the blood, and the comparison group 4 excludes the paniculate swallowwort root and the cassia twig which have the function of enhancing the medicine permeability.

3. Evaluation criteria

The evaluation is carried out according to the Chinese medicine disease diagnosis curative effect standard established by the State administration of traditional Chinese medicine 1994 and the Japanese N.Nakal evaluation standard.

And (3) curing: the waist and leg pain disappears, the test of straight leg elevation is more than 70 degrees, the waist joint activity is normal (0-45 degrees of anteflexion, 0-30 degrees of posterior extension, 0-40 degrees of left and right rotation and 0-50 degrees of left and right lateral flexion), and the original work or primary activity is recovered.

Improvement: the pain in the waist and the lower extremities is obviously relieved, the movement is basically normal, the straight leg elevation test is about 60 degrees, and the movement of the waist joint is basically normal (0-40 degrees of anteflexion, 0-25 degrees of hind extension, 0-35 degrees of left and right rotation and 0-40 degrees of left and right lateral flexion).

The disease is not cured: symptoms and physical signs are not improved before and after treatment, pain is not changed, and functional activity is disturbed.

VAS pain score: visual analog Scale/Score, using a vernier caliper with 10 scales, 0 for no pain and 10 for intolerable pain, allows the patient to indicate the approximate value of pain. Specifically, scores of 3 or less indicate slight pain, which is tolerable and does not affect sleep, scores of 4 to 6 indicate pain and affects sleep, while scores of 7 to 10 indicate strong pain, which is intolerable, and affects appetite and sleep.

4. Evaluation results

Table 1.1:

note: the table is data collected after three treatment courses, wherein 10 treatments are one treatment course.

The cure rate is the number of cure/total cases; effective rate (cure + improvement)/total number of cases.

Description of the drawings: the experimental group of table 1.1 illustrates the performance of the present invention in terms of cure rate and effectiveness. After the polygonum cuspidatum which is a monarch drug is removed from the control group 1, the cure rate is zero, but because the effect of the ministerial drug is close to that of the monarch drug, the lower effective rate can be shown, which shows the importance of the polygonum cuspidatum in the components; the curative ratio of the control group 2 after eliminating the medicines with the functions of dispelling wind and eliminating dampness is obviously reduced compared with that of the experimental group, but the effective rate is higher than that of the control group 1, which shows the effectiveness of the components on non-rheumatic symptoms and further shows the importance of notopterygium root, radix angelicae pubescentis, radix clematidis, monkshood and radix aconiti agrestis; the control group 3 excludes the medicines with the effects of enriching and activating blood, such as the caulis spatholobi, the angelica, the safflower and the ligusticum wallichii, and although the cure rate is low, the effective rate is improved compared with the control group 2, which shows that the effects of enriching and activating blood on patients are positive, but the effect of the lack of the components on the cure effect is large; the control group 4 excludes the paniculate swallowwort root and the cassia twig which have the effect of enhancing the drug permeability, and the effective rate is equivalent to that of the experimental group from the viewpoint of the curative effect, which shows that the paniculate swallowwort root and the white mustard seed which have the effect of enhancing the permeability have limited influence on the curative effect, but the paniculate swallowwort root has certain efficacy of dispelling wind and eliminating dampness, and has certain influence on the cure rate when the paniculate swallowwort root is not added.

Table 2.1:

table 2.1 the VAS pain scores were collected after the first, second and third course of treatment, the score in this table being the mean of all cases.

FIG. 1 is a line graph of the data in Table 2.1, and it can be seen from FIG. 1 that the VAS pain scores for each control group substantially match the efficacy rates presented in Table 1.1 after three treatment sessions.

Fig. 1 shows not only the effective rate but also the speed of the therapeutic effect to some extent, and the steeper the curve, the faster the therapeutic effect. The experimental group of cases obtained the best efficacy after three courses of treatment. The control group 1 in table 1.1 exhibited the lowest effective rate, and the worst and slowest therapeutic effect was also shown in fig. 1. In the control group 4, only the two drugs with the effect of enhancing drug penetration, namely the paniculate swallowwort root and the cassia twig, are removed, so that the curative rate is not as high as that of the experimental group from table 1.1, but the effective rate is the same as that of the experimental group, and by combining the figure 1, the situation that the curative effect is slowed down possibly due to the lack of the paniculate swallowwort root and the cassia twig can be presumed, and a better curative rate can be obtained possibly after the treatment course is increased. Also, since the curves of the control groups 1 to 3 show a tendency to be flatter and flatter, it is presumed that the patients had some relief and therapeutic effects in the early stage of the treatment with the control groups 1 to 3 and may no longer be able to act in the later stage.

Example 4:

2-4, the spinal auxiliary treatment device comprises a traction device and a dressing 3, wherein the traction device is composed of a bearing part 6, a traction part and a stretching part, the bearing part 6 is fixedly arranged at a position higher than the human body, the traction part is connected with the stretching part and the bearing part 6, the stretching part enables the traction force of the traction part to act on the human body to pull the spinal column along the length direction of the spinal column, and the dressing 3 is contacted with the skin around the spinal column and is detachably connected with the traction device. Stretching portion is including tying up first bandage 2 on the people's health, first bandage 2 is connected with traction portion, be equipped with connecting band 4 on the first bandage 2, the other end of connecting band 4 is connected with second bandage 5. The dressing 3 comprises a medicine bag 301 and a fixing part 303, the connecting belt 4 and the fixing part 303 are respectively provided with a first connecting piece 401 and a second connecting piece which are matched with each other, so that the connecting belt 4 and the fixing part 303 can be detachably and fixedly connected, and the medicine bag 301 can be detachably fixed between the connecting belt 4 and the fixing belt. The traction part comprises a traction rope 1 connected with a first bandage 2 and a rope binder for binding the traction rope 1 into a bundle above the first bandage 2. The bearing part 6 comprises a wheel disc, and the traction rope 1 passes through the rope binding device and then bypasses the wheel disc.

The working principle is as follows:

during the use, the 2 ligatures of first bandage are in people's armpit, are connected with a plurality of tractive lines 1 on the first bandage 2, and tractive line 1 is through a bundle rope ware integration branch in the human top, then walks around the rim plate in the bearing portion 6, and the rim plate is located the human directly over, and the rim plate both plays the effect of bearing and can change the direction of force again. The first binding band 2 is pulled upwards by the pulling rope 1 due to the external applied pulling force, so that the spine is naturally stretched under the action of the external pulling force and the self gravity of a person. The second strap 5 is tied under the first strap 2 and the second strap 5 acts to stretch the dressing 3 so that the dressing 3 extends along the length of the spine and lies against the skin at the spine.

The embodiment utilizes the traction device to carry out vertical traction on the spinal part, so that the spinal is physically dragged under the action of traction force and the self gravity of a human body, the gap between the vertebrae of the spinal is properly increased, the original dislocated vertebrae can be slightly restored, and the pain of a patient is relieved by matching with the drug therapy in the dressing 3. In applying traction, the traction weight may be started at 60% of its own weight, and then gradually increased, preferably by more than 5kg, until it increases to equal or slightly greater than its own weight.

It should be noted that the first strap 2 is used for stretching the spine upwards when being tied to the human body, the pulling force of the pulling rope 1 is applied to the first strap 2, and the first strap 2 is made of a firmer material, such as nylon, a belt or a woven belt. In addition, can set up additional strengthening in the position that first bandage 2 corresponds with the user armpit, increase the area of contact of first bandage 2 and user armpit position, when making the user receive ascending pulling force, the armpit position has extra holding power, improves user's comfort level.

It should be noted that the pulling rope 1 and the first strap 2 can be matched in several ways: 1. the first binding belt 2 is provided with a through hole matched with the traction rope 1, so that the traction rope 1 passes through the through hole and is fixedly connected with the first binding belt 2. 2. If first bandage 2 adopts comparatively soft material, when pulling force acted on first bandage 2 through pulling rope 1, aroused easily that first bandage 2 warp, long-term use can cause serious wearing and tearing easily. A metal loop may be provided at the through hole of the first strap 2 so that the traction rope 1 is in contact with the metal loop to avoid direct contact with the first strap 2. 3. The first strap 2 and the traction rope 1 are integrally formed by weaving.

It should be noted that the connecting strip 4 serves to connect the first strap 2 and the second strap 5, both the connecting strip 4 and the second strap 5 being intended to provide better contact of the dressing 3 with the user, the connecting strip 4 serving both to connect the second strap 5 and to mount the dressing 3. Therefore, the connection belt 4 has a plurality of arrangements and can be arranged as a plurality of thin belts. In the present embodiment, the connecting tape 4 is preferably sheet-like as shown in the figure. The connection between the connecting band 4 and the first bandage 2 and the second bandage 5 can be fixed connection or can be detachably fixed connection.

In addition, in this embodiment, it is not specifically limited which portion of the connecting band 4 and the fixing portion 303 contacts with the user, and the drawings in the specification show that the fixing portion 303 is the side close to the skin of the user, and in the specific implementation, no matter the connecting band 4 or the fixing portion 303 is the side contacting with the user, it should be known that the side contacting with the user should be made of a permeable material so as not to affect the treatment of the drug and allow the drug to smoothly permeate into the skin of the user, based on the common knowledge of those skilled in the art.

It should be noted that the first connecting member 401 and the second connecting member are preferably magic tapes which can be attached to each other, and since the dressing 3 needs to be attached to the skin, the magic tapes are soft, low in cost, convenient to detach and mount, and most preferable for achieving detachable fixed connection. In addition, the first connecting member 401 and the second connecting member may also be selected from other members capable of realizing detachable fixed connection in the prior art, such as a lock catch and the like.

The rope binding device is positioned above the user, and the preferred position of the rope binding device is the top of the head of the human body. Because the binding position of the first binding belt 2 is away from the top of the head of a human body by a certain distance, the installation position of the rope binding device is not too low in order not to influence a user. In addition to the examples of the belaying devices provided in the drawings of the specification, the belaying device may also be in the form of a ring with a larger diameter, the transition of the pulling rope 1 from the first strap 2 to the belaying device being more gradual.

Effect verification:

1. case selection criteria were the same as in example 3.

2. Group arrangement

20 cases in each group. And (3) comprehensive group: the auxiliary treatment device in this example was used with the drugs in the experimental group of example 3; the traditional Chinese medicine comprises: the drugs in the experimental group of example 3; a traction group: only the auxiliary treatment device in this example was used, which contained no drug.

3. Evaluation criteria

The same VAS pain scoring system as in example 3 was used, with data acquisition time before treatment, after 10 treatments, and after 20 treatments. The data in the table are the average of the VAS scores in each group.

4. Evaluation results

Table 3.1:

note: effective rate 10 ═ 100% before treatment (before-10 treatments)/before treatment

Effective rate 20 ═ 100% before treatment (before-20 treatments)/before treatment

Description of the drawings: table 3.1 can show that the combination therapy, the traditional Chinese medicine therapy only or the traction therapy only has a certain effect, but the effect of the combination therapy is the best, and the effect of the single traditional Chinese medicine therapy is better than that of the single traction therapy. In addition, as can be surmised from table 2.1, the traditional Chinese medicine group can also show higher effective rate after more treatment courses, and therefore, the spinal column auxiliary treatment device plays a certain role in accelerating the treatment.

Example 5:

compared with the existing external plaster for treating lumbar disc herniation, the plaster provided by the invention has the advantage that the using effect of the plaster is verified.

The existing external plaster is selected from blood circulation promoting and pain relieving plaster, Chinese medicine quasi-character Z34020905, which is composed of dried ginger, kaempferia galangal, angelica dahurica, nardostachyos root and rhizome, rhubarb, arisaema cum bile, raw pinellia ternate, myrrh, frankincense, borneol, menthol, camphor, dried orange peel, angelica, clove, pepper, cortex periplocae, asarum, schizonepeta, cassia twig, biond magnolia flower, ligusticum wallichii, radix angelicae pubescentis, moutan bark, hot pepper, rhizoma atractylodis, belladonna fluid extract and methyl salicylate. In the prescription, dried ginger, kaempferia galangal, angelica dahurica and rhizoma nardostachyos are used for warming the middle-jiao to dispel cold, and regulating qi to alleviate pain; rhizoma arisaematis and rhizoma Pinelliae have effects of eliminating dampness and phlegm, relieving swelling and resolving hard mass; frankincense, myrrh, angelica, rhizoma ligustici wallichii, cortex moutan and the like have the effects of promoting blood circulation, removing blood stasis and relieving pain; borneol, camphor and the like for relieving swelling and pain; radix Angelicae Pubescentis, cortex Periplocae Radicis, and rhizoma Atractylodis can dispel pathogenic wind-damp and relieve arthralgia; herba asari, herba Schizonepetae, ramulus Cinnamomi, and flos Magnoliae have effects in expelling pathogenic wind and cold, and relieving pain; in combination with pungent and warm herbs such as Ding Xiang, Piper and Chi Cao, etc., it can strengthen the actions of dispelling cold and alleviating pain. The whole formula is mainly based on pungent and warm herbs, and has the effects of promoting blood circulation, relieving pain, relaxing muscles and tendons and dredging collaterals. Can be used for treating arthralgia and myalgia, muscle paralysis, sputum nodule, and arthralgia.

The comparative process is as follows:

1. the case selection criteria were the same as those of example 3.

2. Experimental group and control group settings

Two experimental groups and one control group were set, with 20 cases each.

Experimental group 1: the external medicine is prepared by 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of gentiana macrophylla, 10g of paniculate swallowwort root, 10g of angelica, 10g of safflower, 10g of szechuan lovage rhizome, 10g of sappan wood, 10g of turmeric and 5g of white mustard seed according to the most preferable preparation method in the embodiment 3 (namely, old wine with the temperature of more than 50 degrees is selected as a solvent);

experimental group 2: the external medicine is prepared by 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of gentiana macrophylla, 10g of paniculate swallowwort root, 10g of angelica, 10g of safflower, 10g of ligusticum wallichii, 10g of sappan wood, 10g of turmeric and 5g of brassica alba boiss according to the most preferable preparation method in the embodiment 3 (namely, old wine with the temperature of more than 50 degrees is selected as a solvent), and the medicine is matched with the spinal auxiliary treatment device in the embodiment 4 for use;

control group: only the blood-activating pain-relieving plaster is used.

3. Evaluation criteria

The same VAS pain scoring system as in example 3 was used, with data acquisition time before treatment, after 10 treatments, and after 20 treatments.

4. Comparison results

Table 4.1:

Description of the drawings: as can be seen from Table 4.1, the effect obtained by using the pharmaceutical composition of the present invention alone is slightly superior to that obtained by the blood-activating pain-relieving plaster, and when the pharmaceutical composition of the present invention is used in combination with an auxiliary therapeutic device, a significant improvement in the therapeutic effect occurs. The blood circulation promoting pain relieving plaster has certain pain relieving effect on various symptoms due to the complex components, wide treatment range and lack of targeted treatment direction, so the blood circulation promoting pain relieving plaster shows the treatment effect on the directionally selected cases which is not as good as the treatment effect of the medicine components of the invention on the directionally selected cases.

Example 6:

this embodiment proposes another specific structure of the stretching section on the basis of embodiment 4.

As shown in fig. 5 to 7, the stretching part includes a first band 2 to be bound on the human body, the first band 2 is connected to the traction part, a connection band 4 is provided on the first band 2, and a second band 5 is connected to the other end of the connection band 4. The first binding belt 2 comprises a structural ring 201 bearing pulling force and a coating layer sleeved outside the structural ring 201, and the coating layer extends outwards at one side far away from the bearing part 6 to form an annular secondary belt 202; the first bandage 2 is provided with a plurality of through holes at the position close to the structural ring 201, and the first bandage 2 is provided with a hanging foot 7 structure wound around the structural ring 201; the lifting foot 7 is formed in an annular structure by enabling a single binding band material to penetrate through the through hole and be attached to the outside of the first binding band 2 end to end, a fixing end portion is arranged at the position where the first binding band is attached to the end, and a pressing ring 701 facilitating the force application of the end portion of the pulling rope 1 is arranged at the fixing end portion.

Different from the above fixing mode, the structural ring 201 is made of a material with high structural strength, and is generally made of a nylon material or other high polymer materials, wherein the nylon material has high tensile strength and is made of a soft material, so that the structural ring is convenient to bind on the surface of a human body to conform. While the lower sub-band 202 material is used to widen the entire first strap 2 and to connect the integrally formed connecting band 4. And because first bandage 2 is the structure of tieing up in human armpit, can see in fig. 5 and fig. 6, first bandage 2 upper portion is the structure ring 201 that is equipped with the parcel layer for the cover, and the cross-sectional shape of this structure ring 201 is similar circular structure, and the people has higher travelling comfort when being in the state of suspending in midair, avoids forming great surface pressure because of area of contact is less.

The hanging foot structure is also a soft belt-shaped structure with higher tensile property, the head and the tail of the hanging foot structure are attached and fixed, the fixing mode comprises viscose glue, suture connection and the like, and the pressing ring is made of metal materials and has higher structural strength.

Example 7:

this embodiment provides an alternative means of securing the pack 301 to the embodiment 4.

Be equipped with dressing 3 on connecting band 4, dressing 3 includes cartridge bag 301 and fixed part 303, fixed part 303 is network structure to all be equipped with the ligature area at last lower tip, through passing connecting band 4 with the ligature area and tie up behind one's back and form the fixing force to cartridge bag 301.

The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. An external medicine for treating spinal diseases is characterized in that: the method comprises the following raw materials: 25-40g of giant knotweed rhizome, 10-15g of notopterygium root, 10-15g of radix angelicae pubescentis, 10-15g of radix clematidis, 8-12g of radix aconiti agrestis, 10-15g of prepared arisaema tuber, 8-12g of turmeric, 10-15g of sappan wood, 10-15g of suberect spatholobus stem, 10-15g of erythrina bark, 10-15g of garden balsam stem, 5-10g of obscured homalomena rhizome, 9-12g of schizophragma integrifolium, 5-10g of large-leaved gentian, 5-10g of paniculate swallowwort root, 8-12g of Chinese angelica, 6-12g of safflower, 5-10g of.

2. The external medicine for treating spinal diseases according to claim 1, wherein: the method comprises the following raw materials: each part of the traditional Chinese medicine composition comprises 30g of giant knotweed rhizome, 12g of notopterygium root, 12g of pubescent angelica root, 12g of clematis root, 12g of common monkshood mother root, 12g of kusnezoff monkshood root, 12g of prepared arisaema tuber, 12g of turmeric, 12g of sappan wood, 12g of suberect spatholobus stem, 15g of erythrina bark, 15g of garden balsam stem, 10g of obscured homalomena rhizome, 10g of schizophragma integrifolium, 10g of large-leaved gentian, 10g of paniculate swallowwort root.

3. The external medicine for treating spinal diseases according to claim 1 or 2, wherein: is prepared by the following steps:

s1, grinding all the raw materials into fine powder of 100 meshes;

s2, steaming the medicinal powder over water for 25-35 minutes;

s3, adding the medicinal powder obtained in the step S2 into 500ml of solvent.

4. The external medicine for treating spinal diseases according to claim 3, wherein: the solvent is white spirit or old wine with the alcohol degree of more than 50.

5. A spinal column auxiliary treatment device is characterized in that: the spinal column traction device comprises a traction device and a dressing (3) containing the external medicine for treating the spinal column diseases, wherein the traction device is composed of a bearing part (6), a traction part and a stretching part, the bearing part (6) is fixedly arranged at a position higher than a human body, the traction part is connected with the stretching part and the bearing part (6), the stretching part enables the traction force of the traction part to act on the human body to pull the spinal column along the length direction of the spinal column, and the dressing (3) is in contact with the skin around the spinal column and is detachably connected with the traction device.

6. The spinal supplemental treatment device of claim 5, wherein: tensile portion is including tying up first bandage (2) on the people's health, first bandage (2) are connected with traction portion, be equipped with connecting band (4) on first bandage (2), the other end of connecting band (4) is connected with second bandage (5).

7. The spinal supplemental treatment device of claim 6, wherein: the traction part comprises a traction rope (1) connected with the first bandage (2) and a rope binding device which integrates the traction rope (1) into one bundle above the first bandage (2); the bearing part (6) comprises a wheel disc, and the traction rope (1) passes through the rope binding device and then bypasses the wheel disc.

8. The spinal supplemental treatment device of claim 7, wherein: the dressing (3) comprises a medicine bag (301) and a fixing part (303), wherein a first connecting piece (401) and a second connecting piece which are matched with each other are respectively arranged on the connecting band (4) and the fixing part (303) to enable the connecting band (4) and the fixing part (303) to be detachably and fixedly connected, and the medicine bag (301) contains medicines and is detachably fixed between the connecting band (4) and the fixing part (303); the medicine bag (301) is provided with a positioning hole (302) corresponding to the first connecting piece (401).

9. The spinal supplemental treatment device of claim 7, wherein: the first binding belt (2) comprises a structural ring (201) bearing pulling force and a coating layer sleeved outside the structural ring (201), and the coating layer extends outwards on one side far away from the bearing part (6) to form an annular secondary belt (202); the first bandage (2) is provided with a plurality of through holes at the position close to the structural ring (201), and the first bandage (2) is provided with a hanging foot (7) structure for winding the structural ring (201); the lifting foot (7) is formed into an annular structure by penetrating a through hole through a single bandage material and attaching the first bandage (2) to the outside end to end, a fixed end part is arranged at the attaching position of the end to end, and a pressing ring (701) which is convenient for the force application of the end part of the pulling rope (1) is arranged at the fixed end part.

10. The spinal supplemental treatment device of claim 7, wherein: be equipped with dressing (3) on connecting band (4), dressing (3) are including cartridge bag (301) and fixed part (303), fixed part (303) are network structure to all be equipped with the ligature area under last tip, through passing connecting band (4) with the ligature area and tie up behind one's back and form cartridge bag (301) fixed power.